11.52
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
What drives Nurix Therapeutics Inc. stock priceTremendous financial leverage - PrintWeekIndia
Nurix Therapeutics Inc. Stock Analysis and ForecastPhenomenal returns - PrintWeekIndia
Massachusetts Financial Services Co. MA Decreases Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight - GlobeNewswire Inc.
Is Nurix Therapeutics Inc. a good long term investmentExceptional trading results - Autocar Professional
Hussman Strategic Advisors Inc. Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 5.4%What's Next? - MarketBeat
Janux Therapeutics Receives Buy Rating from Leerink Partners Amid Strategic Initiatives and Long-Term Growth Potential - AInvest
What analysts say about Nurix Therapeutics Inc. stockUnmatched profit potential - jammulinksnews.com
Q3 EPS Forecast for Nurix Therapeutics Raised by Analyst - MarketBeat
Janux Therapeutics (JANX) Soars 2.31% on R&D Day Announcement - AInvest
Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress By Investing.com - Investing.com South Africa
Nurix Therapeutics’ SWOT analysis: biotech stock’s pivotal trials and pipeline progress - Investing.com Australia
When (NRIX) Moves Investors should Listen - news.stocktradersdaily.com
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright - Yahoo Finance
NRIX: Morgan Stanley Lowers Price Target for Nurix Therapeutics - GuruFocus
A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts - Benzinga
Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $34.00 at HC Wainwright - MarketBeat
H.C. Wainwright Adjusts Price Target for Nurix Therapeutics (NRI - GuruFocus
Navigating Nurix Therapeutics' Early-Stage Biotech Landscape: A Strategic SWOT Analysis - AInvest
Broker Revenue Forecasts For Nurix Therapeutics, Inc. (NASDAQ:NRIX) Are Surging Higher - simplywall.st
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Price Target Cut to $30.00 by Analysts at Oppenheimer - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Issues Earnings Results - MarketBeat
Nurix Therapeutics: The BTK Disruptor With Undervalued Upside Potential - AInvest
Nurix Therapeutics Could Disrupt BTK Therapy And Reward Investors (NASDAQ:NRIX) - Seeking Alpha
UBS Group Lowers Nurix Therapeutics (NASDAQ:NRIX) Price Target to $26.00 - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 7.8% After Earnings Beat - MarketBeat
Top 3 Trending Stocks: Ultragenyx Pharmaceutical, Rhythm Pharmaceuticals, and Nurix Therapeutics - AInvest
Stifel Nicolaus Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail
Piper Sandler Keeps Their Buy Rating on Nurix Therapeutics (NRIX) - The Globe and Mail
Nurix Therapeutics (NRIX) Stock Target Price Lowered by UBS Anal - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):